<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26131422</article-id>
      <article-id pub-id-type="pmc">4446589</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2015.35.4.466</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>An Unusual Case of Myeloperoxidase-Positive Acute Megakaryoblastic Leukemia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Hyeyoung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Yonggoo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Yoo-Jin</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Han</surname>
            <given-names>Kyungja</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Kyungja Han. Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea. Tel: +82-2-2258-1644, Fax: +82-2-2258-1719, <email>hankja@catholic.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <volume>35</volume>
      <issue>4</issue>
      <fpage>466</fpage>
      <lpage>468</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>16</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor</p>
    <p>We report an unusual case of myeloperoxidase (MPO)-positive acute megakaryoblastic leukemia (AMKL). The patient was a 63-yr-old woman referred to our hospital with anemia and dyspnea. General physical examination revealed no lymphadenopathy or hepatosplenomegaly. An initial complete blood count indicated white blood cell counts of 26.78&#xD7;10<sup>9</sup>/L, including 47% blasts, hemoglobin of 7.2 g/dL, and platelets of 519&#xD7;10<sup>9</sup>/L. A peripheral blood smear showed blasts with prominent nucleoli and blue cytoplasm. Some giant platelets were also observed. A bone marrow (BM) biopsy showed hypercellularity with no fibrosis, packed with blasts, and revealed an increase in megakaryocyte number. BM aspirates showed that blasts accounted for 70% of all nucleated elements. Most blasts had medium-to-large, finely chromatinated nuclei with distinct nucleoli. Some showed multiple clear cytoplasmic projections (<xref ref-type="fig" rid="F1">Fig. 1A, B</xref>) or Auer rods. No dysplastic features of hematologic precursors were observed. Cytochemical stain showed some blasts were MPO-positive (<xref ref-type="fig" rid="F1">Fig. 1C</xref>) but negative for periodic acid-Schiff (PAS) stain and non-specific esterase (NSE, &#x3B1;-naphthyl butyrate).</p>
    <p>Immunophenotyping showed a distinct population in the CD45 vs. SSC plot that was positive for CD7, CD11c, CD13, CD33, CD41a, CD117, cytoplasmic MPO, and HLA-DR and negative for CD2, CD3, CD5, CD10, CD14, CD19, CD20, CD22, CD34, CD56, CD64, and cytoplasmic CD79a. About 57.0% of blasts were CD41a-positive, and 57.7% were cytoplasmic MPO-positive. A blast population co-expressing CD41a and cytoplasmic-MPO was also observed (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Conventional karyotyping revealed a 46,XX karyotype. Molecular studies did not reveal any genetic abnormalities. As the patient refused treatment, only supportive care was provided, and the patient died from pneumonia four months later.</p>
    <p>Diagnosis of AMKL relies on multiple criteria including morphology, immunophenotyping, cytochemical stain, and ultrastructural studies [<xref rid="B1" ref-type="bibr">1</xref>]. The standard for diagnosis is demonstration of platelet glycoprotein (GP)-CD41 (GP IIb/IIIa) and/or CD61 (GP IIIa) by immunophenotyping. Cytoplasmic expression is more specific owing to possible contamination of platelets [<xref rid="B2" ref-type="bibr">2</xref>]. In cytochemical stain, megakaryoblasts are not reactive with MPO or Sudan Black B. Cells of the megakaryocytic lineage are usually positive in PAS stain owing to glycogen granules in the cytoplasm, and they are typically present in the periphery on stain, with prominent cytoplasmic blebs [<xref rid="B3" ref-type="bibr">3</xref>]. Reactivity with &#x3B1;-naphthyl acetate, but not with &#x3B1;-naphthyl butyrate, a different substrate for NSE, is characteristic of megakaryoblasts [<xref rid="B4" ref-type="bibr">4</xref>]. An ultrastructural platelet peroxidase reaction by cytochemistry, while difficult to perform, is also diagnostic for megakaryoblasts [<xref rid="B1" ref-type="bibr">1</xref>]. Megakaryoblasts also show acid phosphatase reactivity localizing to the Golgi [<xref rid="B4" ref-type="bibr">4</xref>]. There are no distinct chromosomal abnormalities, but inv(3)(q21q26.2) and t(3:3)(q21q26.2) are associated with megakaryocytic/megakaryoblastic differentiation [<xref rid="B2" ref-type="bibr">2</xref>].</p>
    <p>Although MPO is an exclusive marker for leukemia of the megakaryoblastic lineage, few MPO-positive AMKL cases have been reported [<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>]. Park et al. [<xref rid="B5" ref-type="bibr">5</xref>] reported one Korean case in 1996, where blasts showed morphology typical of megakaryoblasts, and CD61 expression was confirmed by flow cytometry. The blasts also were weakly positive for MPO in cytochemical stain, and some Auer rods were observed. The sample was PAS-negative, but positive foci in the Golgi were observed with NSE stain (&#x3B1;-naphthyl acetate). Tallman et al. [<xref rid="B6" ref-type="bibr">6</xref>] reviewed 20 patients previously diagnosed as having AMKL using morphologic evidence and found two MPO-positive patients. One patient expressed factor VIII, a megakaryocytic lineage marker, and karyotyping revealed t(3:3)(q21;q26). The other patient had a normal karyotype and no evidence of the megakaryocytic lineage. In another study, AMKL was diagnosed by using another platelet marker, CD31, with MPO [<xref rid="B7" ref-type="bibr">7</xref>]. CD31, also known as PECAM-1 (platelet endothelial cell adhesion molecule 1), is a 130-kDa transmembrane glycoprotein on the surface of platelets, monocytes, macrophages, and neutrophils [<xref rid="B8" ref-type="bibr">8</xref>]. Immunolocalization of CD31 is limited to megakaryocytes in normal BM or in cases of myelofibrosis [<xref rid="B9" ref-type="bibr">9</xref>]. A failed BM aspiration prevented analysis by flow cytometry. The sample was negative for factor VIII on immunohistochemistry. However, the authors diagnosed the case as AMKL on the basis of typical blast morphology and positive immunohistochemical reactivity for CD31, CD43, and MPO in the BM biopsy [<xref rid="B7" ref-type="bibr">7</xref>].</p>
    <p>In this case, blasts showed typical megakaryoblastic morphology with some Auer rods. Unlike most cases, the blasts co-expressed CD41a and cytoplasmic-MPO, were MPO-positive on cytochemical stain, and PAS-negative. According to the 2008 WHO classification, megakaryocytic lineage markers are not included in the diagnosis of mixed phenotype acute leukemia [<xref rid="B10" ref-type="bibr">10</xref>]. On the basis of previous reports, we conclude that this was an MPO-positive AMKL. AMKL is rare, and its diagnosis is not clearly defined compared with other types of AML. Morphologic evidence is still important, and comprehensive analyses are required when diagnosing acute leukemia, especially with a megakaryocytic lineage.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mathur</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Congenital acute megakaryocytic leukemia</article-title>
          <source>Indian J Med Paediatr Oncol</source>
          <year>2011</year>
          <volume>32</volume>
          <fpage>165</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="pmid">22557786</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Arber</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Brunning</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Orazi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Porwit</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Thiele</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <chapter-title>Acute myeloid leukemia, not otherwise specified</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Pileri</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <source>WHO classification of tumours of haematopoietic and lymphoid tissues</source>
          <edition>4th ed</edition>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC</publisher-name>
          <year>2008</year>
          <fpage>130</fpage>
          <lpage>139</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Sun</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <source>Flow cytometry, immunohistochemistry, and molecular genetics for hematologic neoplasms</source>
          <year>2012</year>
          <edition>2nd ed</edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
          <year>2012</year>
          <fpage>150</fpage>
          <lpage>152</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pombo De Oliveira</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Gregory</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Matutes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Parreira</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Catovsky</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Cytochemical profile of megakaryoblastic leukaemia: a study with cytochemical methods, monoclonal antibodies, and ultrastructural cytochemistry</article-title>
          <source>J Clin Pathol</source>
          <year>1987</year>
          <volume>40</volume>
          <fpage>663</fpage>
          <lpage>669</lpage>
          <pub-id pub-id-type="pmid">3038965</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>YS</given-names>
            </name>
          </person-group>
          <article-title>A case of acute megakaryoblastic leukemia showing Aure rods</article-title>
          <source>Korean J Hematol</source>
          <year>1996</year>
          <volume>31</volume>
          <fpage>161</fpage>
          <lpage>165</lpage>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tallman</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Neuberg</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Francois</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Paietta</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wiernik</surname>
              <given-names>PH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience</article-title>
          <source>Blood</source>
          <year>2000</year>
          <volume>96</volume>
          <fpage>2405</fpage>
          <lpage>2411</lpage>
          <pub-id pub-id-type="pmid">11001891</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Majhi</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Murhekar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sundersingh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rajalekshmi</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Megakaryoblastic leukemia presenting as pancytopenia and extensive myelofibrosis in a child diagnosed by myeloid markers and CD 31</article-title>
          <source>Indian J Med Paediatr Oncol</source>
          <year>2012</year>
          <volume>33</volume>
          <fpage>59</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">22754213</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pusztaszeri</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Seelentag</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bosman</surname>
              <given-names>FT</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues</article-title>
          <source>J Histochem Cytochem</source>
          <year>2006</year>
          <volume>54</volume>
          <fpage>385</fpage>
          <lpage>395</lpage>
          <pub-id pub-id-type="pmid">16234507</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calapso</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vitarelli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Crisafulli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tuccari</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Immunocytochemical detection of megakaryocytes by endothelial markers: a comparative study</article-title>
          <source>Pathologica</source>
          <year>1992</year>
          <volume>84</volume>
          <fpage>215</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="pmid">1437309</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Borowitz</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Bene</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Porwit</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Matutes</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <chapter-title>Acute leukemias of ambiguous lineage</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Pileri</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <source>WHO classification of tumours of haematopoietic and lymphoid tissues</source>
          <edition>4th ed</edition>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC</publisher-name>
          <year>2008</year>
          <fpage>150</fpage>
          <lpage>155</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>(A, B) Bone marrow aspirates showing megakaryoblasts with cytoplasmic blebs (red arrows) (Wright-Giemsa stain, &#xD7;1,000). (C) Bone marrow megakaryoblasts positive for myeloperoxidase stain (&#xD7;1,000).</title>
      </caption>
      <graphic xlink:href="alm-35-466-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <title>Flow cytometry of the bone marrow sample. (A) CD45/SSC dot plot with the blast population highlighted. (B) FSC/SSC plot of the sample. Blasts are positive for (C) CD41a (57.0%) and (D) cytoplasmic myeloperoxidase (MPO) (57.7%). (E) Back-gating of CD41a.</title>
      </caption>
      <graphic xlink:href="alm-35-466-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
